Patent ID: 7199213

Claim:
A curable composition, comprising: a poly(arylene ether); and a fused alicyclic (meth)acrylate monomer selected from 3α-(meth)acryloyloxyperhydroindene, 3α-(meth)acryloyloxy-7α-hydroxyperhydroindene, 3α,7α-bis[(meth)acryloyloxy]perhydroindene, 4α-(meth)acryloyloxydecalin, 4α,8α-bis[(meth)acryloyloxy]decalin, 4α-(meth)acryloyloxyperhydrofluorene, 4α-(meth)acryloyloxy-9α-hydroxyperhydrofluorene, 4α,9α-bis[(meth)acryloyloxy]perhydrofluorene, 4α-(meth)acryloyloxyperhydroanthracene, 4α-(meth)acryloyloxy-9α-hydroxyperhydroanthracene, 4α,9α-bis[(meth)acryloyloxy]perhydroanthracene, 10α-(meth)acryloyloxyperhydrophenanthrene, 10α-(meth)acryloyloxy-4α-hydroxyperhydrophenanthrene, 4α,10α-bis[(meth)acryloyloxy]perhydrophenanthrene, 2-(meth)acryloyloxytricyclo[5.2.1.0 2,6 ]decane, 2-(meth)acryloyloxy-6-hydroxytricyclo[5.2.1.0 2,6 ]decane, 2,6-bis[(meth)acryloyloxy]tricyclo[5.2.1.0 2,6 ]decane, 2,5-bis[(meth)acryloyloxy]tricyclo[5.2.1.0 2,6 ]decane, 2α-(meth)acryloyloxyperhydroacenaphthene, 2α-(meth)acryloyloxy-8α-hydroxyperhydroacenaphthene, 2α,8α-bis[(meth)acryloyloxy]perhydroacenaphthene, 3α-[(meth)acryloyloxy]perhydroacenaphthene, 3α-(meth)acryloyloxy-9α-hydroxyperhydroacenaphthene, 3α,9α-bis[(meth)acryloyloxy]perhydroacenaphthene, and combinations of the foregoing fused alicyclic (meth)acrylate monomers.